N/A
N=161
Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American Men
Prostate Cancer
Bottom Line
View on ClinicalTrials.gov: NCT03869216 ↗Enrolled (actual)
161
Serious AEs
0.0%
Results posted
Dec 2025
Primary outcome: Primary: Shared Decision-making — 12.54; 12.15 Units on a scale — p=0.8388
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Educational Shared Decision-Making Intervention (Behavioral)
- Age
- Adult, Older Adult · 40+ yrs
- Sex
- Male
- Sponsor
- Xavier University of Louisiana.
- Primary completion
- Nov 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Shared Decision-making |
12.54; 12.15 | 0.8388 |
| SECONDARY Quality of Decision (QD) |
82.23; 80.45 | 0.4929 |
| SECONDARY Preference-Congruent Decision Making |
36; 40; 24; 13 | 0.1216 |
Summary
This behavioral clinical trial assesses the efficacy of a educational intervention to increase shared decision making about prostate-specific antigen (PSA)-based screening for prostate cancer among African American males. Half of participants will receive a multimedia educational intervention, while the other half will receive usual care.
Eligibility Criteria
Patient Inclusion Criteria:
- Receiving care at the clinical sites
- Identify as African American male
- Ages 40-69 years old
Patient Exclusion Criteria:
- Personal history of prostate cancer at the time of consent
- Cognitive impairment that would interfere with participation in the study
- Unable to complete any aspect of the intervention within the specified time limit
Data sourced from ClinicalTrials.gov (NCT03869216). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.